 | Study programme 2025-2026 | Français | |
| Pharmaco-économie | |||
Learning Activity |
| Code | Lecturer(s) | Associate Lecturer(s) | Subsitute Lecturer(s) et other(s) | Establishment |
|---|---|---|---|---|
| M-DOYM-237 |
|
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term |
|---|---|---|---|---|---|---|---|
| Français | Français | 5 | 1 | 0 | 0 | 0 | Q1 |
Content of Learning Activity
The objective of this course is to understand the role and implementation of the pharmaco-economics in the assessment of the reimbursement request of new drugs. In a context of budgetary constraints, does the access to a new drug present a cost-effective ratio at the proposed price ? The course will review the basics of pharmaco-economics.Thanks to a good understanding of these concepts, the students will also be able to acquire a critical mind when reviewing papers on this topic.
Required Learning Resources/Tools
Not applicable
Recommended Learning Resources/Tools
Not applicable
Other Recommended Reading
Cleemput I, Neyt M, Van de Sande S, Thiry N. Belgian guidelines for economic evaluations and budget impact analyses : second edition. Health Technology Assessment (HTA) Brussels : Belgian Health Care Knowledge Centre (KCE) : 2012. KCE report 183C. D/212/10.273/54
Mode of delivery
- Face-to-face
Type of Teaching Activity/Activities
- Cours magistraux
- Etudes de cas
Evaluations
The assessment methods of the Learning Activity (AA) are specified in the course description of the corresponding Educational Component (UE)
Location of learning activity
- Université de Mons - Mons
Location of assessment
- Université de Mons - Mons